Prudence A Francis

12PUBLICATIONS
111CO-AUTHORS
Predictive and prognostic markersExercise physiologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 24, 2025
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.

Stephen J Luen, Lauren C Brown, Courtney T van Geelen

|Jan 13, 2025
Supervised Exercise for Patients With Metastatic Breast Cancer: A Cost-Utility Analysis Alongside the PREFERABLE-EFFECT Randomized Controlled Trial.

Aniek E M Schouten, Anouk E Hiensch, Geert W J Frederix

|Oct 21, 2024
Sustained lymphocyte decreases after treatment for early breast cancer.

Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke

|Jul 25, 2024
Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial.

Anouk E Hiensch, Johanna Depenbusch, Martina E Schmidt

|Jul 02, 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.

Sabashini K Ramchand, Ali Ghasem-Zadeh, Rudolf Hoermann

|Dec 15, 2022
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.

Olivia Pagani, Barbara A Walley, Gini F Fleming

Pageof 2

Frequent Collaborators

7 joint publications

Sherene Loi

4 joint publications

Roberto Salgado

3 joint publications

Courtney T van Geelen

3 joint publications

Christos Sotiriou